Zobrazeno 1 - 10
of 33
pro vyhledávání: '"T W, Van Haeften"'
Autor:
Frank L.J. Visseren, T. W. Van Haeften, Annemarie M J Wassink, Y. van der Graaf, Wilko Spiering, Sabita S. Soedamah-Muthu
Publikováno v:
Diabetic Medicine. 28:932-940
Aims To assess the effect of various measures of adiposity and of metabolic risk factors, both separately and in combination, on the risk of future Type 2 diabetes in patients with manifest vascular diseases. Methods This was a prospective cohort stu
Autor:
T W van Haeften, R Achterbergh, R de Vries, B Suelmann, A den Boer, J Wiebolt, S van der Leij, E Marsch
Publikováno v:
European Journal of Endocrinology. 164:789-794
ObjectiveIt is unclear whether Hashimoto's thyroiditis and Graves' disease (often referred to as autoimmune thyroid disease, AITD) cluster to the same extent with other autoimmune disorders.MethodsWe assessed adrenal, β-cell, celiac and gastric anti
Publikováno v:
Hormone and Metabolic Research. 33:361-364
We studied the effect of the acute administration of gliclazide at 160 mg on insulin release during hyperglycaemic clamps in 12 type 2 diabetes patients, age 50 +/- 9.0 years, diabetes duration 5.5 +/- 4.8 years, fasting blood glucose 9.6 +/- 2.1 mmo
Autor:
J. J. M. LIGTENBERG, null A., T. W. VAN HAEFTEN, W. J. SLUITER, W. D. REITSMA, R. P. F. DULLAART
Publikováno v:
Journal of Internal Medicine. 240:233-242
Essential hypertension may be associated with abnormalities in free fatty acids (FFA) and triglyceride metabolism, which could lead to alterations in high density lipoproteins (HDL). Lecithin: cholesterol acyltransferase (LCAT) and cholesteryl ester
Autor:
A M J, Wassink, Y, van der Graaf, T W, van Haeften, W, Spiering, S S, Soedamah-Muthu, F L J, Visseren, P A, Doevendans
Publikováno v:
Diabetic medicine : a journal of the British Diabetic Association. 28(8)
To assess the effect of various measures of adiposity and of metabolic risk factors, both separately and in combination, on the risk of future Type 2 diabetes in patients with manifest vascular diseases.This was a prospective cohort study in 2924 pat
Autor:
M.J.C. Eijkemans, Susanne M. Veltman-Verhulst, H. W. de Valk, T. W. Van Haeften, Angelique J. Goverde, Bart C.J.M. Fauser
Publikováno v:
Human reproduction (Oxford, England). 25(12)
background: Low plasma sex hormone-binding globulin (SHBG) concentrations during pregnancy have been associated with the risk of developing gestational diabetes mellitus (GDM). Women presenting with polycystic ovary syndrome (PCOS) often exhibit low
Publikováno v:
Clinical Science. 81:101-106
1. Sulphonylurea derivatives are commonly used in the treatment of non-insulin-dependent diabetes mellitus. It is, however, unclear whether the hypoglycaemic effect of sulphonylurea derivatives is additive to the effect of glucose, or whether sulphon
Autor:
W. L. Mosterd, L W.E. Sabelis, M. L. Zonderland, P J. Senden, H. J. Hulzebos, T. W. Van Haeften, A. van de Wiel, B. C. M. Te Boekhorst
Publikováno v:
Clinical Science, 106(5), 459. Portland Press Ltd.
Clinical Science, 106(5), 459-466. PORTLAND PRESS LTD
Clinical Science, 106(5), 459-466. PORTLAND PRESS LTD
To determine the effect of training on insulin sensitivity (IS) and how this relates to peak 02 (peak oxygen uptake) in CHF (chronic heart failure), 77 CHF patients (New York Heart Association class, II/III; men/women, 59/18; age, 60 +/- 9 years; bod
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fc2ba893cee0d445127e537646c1575a
https://dspace.library.uu.nl/handle/1874/10606
https://dspace.library.uu.nl/handle/1874/10606
Autor:
J H, van Tilburg, L A, Sandkuijl, L, Franke, E, Strengman, P L, Pearson, T W, van Haeften, C, Wijmenga
Publikováno v:
European journal of clinical investigation. 33(12)
A genome scan was performed in obese type 2 diabetes mellitus pedigrees to identify susceptibility loci involved in obesity-driven type 2 diabetes mellitus. We studied the 20% most obese diabetes pedigrees from a confined Dutch population from around
Publikováno v:
Nederlands tijdschrift voor geneeskunde. 143(45)
Within a few years the 80,000 human genes will be identified which will increase our understanding of the genetic aspects of a large number of diseases, not only the relatively rare monogenic diseases but also the more frequent multifactorial disease